Synkinesis
7
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
71%
5 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis
Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies
Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis
Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy
Mixed Methods Investigation of Chronic Facial Paralysis in Individuals With Synkinesis
Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis